CLAIR CARRAGINO: Open Payments
NPI 1386061612 · GREEN BROOK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 29 payments from 9 companies in 2025. Trend: 2023 $203 · 2024 $389 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $306 |
| Novo Nordisk Inc | 6 | $101 |
| Lilly USA, LLC | 5 | $84 |
| ABBVIE INC. | 3 | $51 |
| Abbott Laboratories | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: AIRSUPRA, MOUNJARO, FREESTYLE LIBRE 3, Wegovy, FARXIGA, UBRELVY, BREZTRI, Kerendia.
Industry payments across NJ — which companies pay providers there.
